https://psychedelicspotlight.com/wp-content/uploads/2021/01/mushroom-spores-psychedelic-spotlight.jpg 667 1000 Jennifer Walker-Journey https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Jennifer Walker-Journey2021-01-12 05:04:172022-06-07 18:53:14What Are Psilocybin Spores? Everything You Need to Know and Grow
What exactly are psilocybin mushroom spores? Are they legal? Here's everything you need to know and how to grow your own.
https://psychedelicspotlight.com/wp-content/uploads/2022/06/maxresdefault-32.jpeg 720 1280 Psychedelic Spotlight https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Psychedelic Spotlight2021-01-10 12:22:462022-06-09 19:17:55Is Compass Pathways a GOOD INVESTMENT? (CMPS stock analysis)
In this episode, we take a deep dive into Compass Pathways (CMPS), a psychedelic-medicines company aiming to treat depression with psilocybin. To understand Compass Pathways (CMPS ), as a company and as an investment, you have to study 5 things: What problem is Compass Pathways trying to solve? CMPS’ clinical trial, treating depression with psilocybin The founders and leaders of Compass Pathways Compass’ Financials Is CMPS stock a good investment for a retail investor? As the psychedelic stocks sector takes off, Compass Pathways, alongside MindMed (MMED / MMEDF), looks poised to lead the pack. No other psychedelic-medicines company is as advanced in a clinical trial as is Compass Pathways (CMPS). CMPS has a phase 2b trial to test the effectiveness of psilocybin in treating Treatment-Resistant Depression could be game changing, and make for a great investment opportunity. Let me know in the comments what you guys think. Is Compass Pathways a GOOD INVESTMENT? Will the CMPS stock skyrocket in 2021? Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. Resources: https://compasspathways.com/ https://www.webmd.com/depression/understanding-depression-basics#1 https://www.psychiatry.org/patients-families/depression/what-is-depression https://www.nimh.nih.gov/health/statistics/major-depression.shtml https://www.webmd.com/depression/guide/depression-treatment-options#1 https://www.ncbi.nlm.nih.gov/books/NBK361016/#:~:text=Inotherwordsantidepressantsare,foundtobeequallyeffective https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-019-2222-4#:~:text=Treatmentresistantdepression(TRD),MDDpatientpopulation1 https://www.beckleyfoundation.org/psilocybin-for-depression-2 https://www.hopkinsmedicine.org/news/newsroom/news-releases/psychedelic-treatment-with-psilocybin-relieves-major-depression-study-shows https://compasspathways.com/our-research/psilocybin-therapy/about-psilocybin-therapy/#from-subnav https://psychedelicreview.com/person/ekaterina-malievskaia/ https://compasspathways.com/team-member/george-goldsmith/ https://compasspathways.com/team-member/lars-christian-wilde/ https://www.reuters.com/article/us-compass-pathways-ipo/peter-thiel-backed-compass-pathways-files-for-u-s-ipo-idUSKBN25O31T https://www.globenewswire.com/news-release/2019/05/15/1825506/0/en/Anxiety-Disorder-and-Depression-Treatment-Market-To-Reach-USD-18-90-Billion-By-2026-Reports-And-Data.html https://www.treehugger.com/facts-about-magic-mushrooms-4868810 https://psychedelicreview.com/person/ekaterina-malievskaia/ #CompassPathways #CMPS #PsychedelicStocks #MindMed #MMED #MMEDF #PsychedelicStocks #ThePsychedelicInvestor
https://psychedelicspotlight.com/wp-content/uploads/2021/01/ehave-psychedelic-spotlight.png 498 1000 Jill Ettinger https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Jill Ettinger2021-01-08 22:44:232021-01-08 22:44:24Psychedelic Business News Spotlight: January 08, 2021
This week in psychedelic business news, Mydecine, Neon Mind, Ehave, and more.
https://psychedelicspotlight.com/wp-content/uploads/2021/01/Copy-of-Simplecast-RECAST-ART.png 1125 2000 Psychedelic Spotlight https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Psychedelic Spotlight2021-01-07 18:57:062021-07-21 22:25:20Interview With Kelsey Ramsden, President and CEO of Mind Cure
Kelsey Ramsden, the President, and CEO of Mind Cure Health Inc. sheds light on the advancements Mind Cure is currently making.
https://psychedelicspotlight.com/wp-content/uploads/2021/01/tattooed-man-psychedelic-spotlight.jpg 667 1000 Jennifer Walker-Journey https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Jennifer Walker-Journey2021-01-06 00:51:272021-01-06 00:52:38Could Psilocybin End Our Addiction Crisis?
Psilocybin is showing potential in addressing the alcoholism and addiction crises, new data find.
https://psychedelicspotlight.com/wp-content/uploads/2021/01/neonmind-psychedelic-spotlight.jpg 420 560 Jill Ettinger https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Jill Ettinger2021-01-05 22:06:152021-01-05 22:06:16NeonMind Takes Psilocybin Therapy Public
NeonMind is the latest psychedelic company to go public. It's the first to launch on the Canadian Stock Exchange in 2021.
https://psychedelicspotlight.com/wp-content/uploads/2021/01/headphones-psychedelic-spotlight.jpg 667 1000 Derek Beres https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Derek Beres2021-01-05 21:34:222021-03-04 00:02:06These 5 Apps Are Made for Taking Psychedelics
Taking psychedelics? There's an app for that. These companies are leading the way with trip guides, support, and more.
https://psychedelicspotlight.com/wp-content/uploads/2021/01/candles-psychedelic-spotlight.jpg 660 1000 Evan Lewis-Healey https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Evan Lewis-Healey2021-01-04 23:53:572021-03-04 00:08:02Psychedelics Cause Ego Death: What You Need to Know
One aspect of the psychedelic experience is something called ego death. Can it help people with mental health issues?
https://psychedelicspotlight.com/wp-content/uploads/2022/06/maxresdefault-31.jpeg 720 1280 Psychedelic Spotlight https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Psychedelic Spotlight2021-01-03 12:22:592022-06-09 19:17:20MindMed’s LSD Neutralizer is GENIUS: MindMed Stock’s Massive Opportunity (MMED/MMEDF) 🚀
In this video, I discuss how MindMed's LSD Neutralizer is GENIUS: MindMed Stock's Massive Opportunity (MMED/MMEDF. 🔥 MindMed has had a impressive run up in 2020. The MMED stock is up nearly 1,130% and what we all wonder is : Could MindMed Stock keep on rising? With a larger psychedelic pipeline than Compass Pathways (CMPS), MindMed has made huge advancements in 2020, one of which is its LSD Neutralizer Technology To Shorten and Stop LSD Trips, which is groundbreaking news for all players in the psychedelic medicines industry. MindMed has a handful of exciting programs in the works, some of which have important milestones coming up this year. Project Lucy is one of these programs, using therapeutic doses of LSD to treat anxiety disorders. If this gets the go-ahead from regulators, it will proceed with a clinical trial investigating LSD for anxiety disorders. If that happens, the mindmed stock could get a big boost. Another boost could be MindMed's potential uplisiting on to the Nasdaq. Currently, the MindMed Stock trades on the Canadian exchange NEO under the symbol MMED. MindMed is also traded in the United States under the symbol MMEDF and in Germany under the symbol MMQ. Remember to Like, Subscribe, and SMAH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMedStock #MindMed #MMED #MMEDF
https://psychedelicspotlight.com/wp-content/uploads/2020/12/new-year-psychedelic-spotlight.jpg 732 1000 Jill Ettinger https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Jill Ettinger2020-12-31 03:12:192021-03-31 16:50:487 Psychedelic Trend Predictions for 2021
The momentum for psychedelics is snowballing, and 2021 is expected to be an even bigger and better year for the industry.